Literature DB >> 6813325

Changes in actin lysine reactivities during polymerization detected using a competitive labeling method.

S E Hitchcock-De Gregori, S Mandala, G A Sachs.   

Abstract

We have studied the structure of actin by measuring the relative reactivities of lysines with acetic anhydride using a competitive labeling procedure comparing monomeric globular actin. monomeric actin in the presence of salt, and filamentous actin polymerized in 100 mM NaCl and 100 mM NaCl, 2 mM MgCl2. We have identified 12 of the 19 lysines: 18, 50, 61, 68, 113, 191, 237, 290, 315, 325, 327, and 358. In all conditions, Lys (325, 327) is the most reactive. In globular actin, Lys 18, 191, 290, 314. and 358 are less than 20% as reactive as Lys (325, 327); the remaining have intermediate reactivities. On polymerization in the presence of NaCl and Mg2+, lysines 50, 61, 68, 113, and 290 become less reactive relative to Lys (325, 327). The changes in Lys 50, 61, and 113 are due largely to the polymerization event whereas those in Lys 68 and 290 appear to be an effect of Mg2+. Lys 18, 191, and 358 increase in relative reactivity when cation is added to the monomer and then become less reactive in the polymer, showing no large overall change in reactivity relative to the monomer in the absence of salt. Lysines that are reduced in reactivity upon polymerization indicate possible contact regions between actin monomers in the filament in the NH2-terminal third of the protein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813325

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region.

Authors:  T Palm; S Graboski; S E Hitchcock-DeGregori; N J Greenfield
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

2.  A periodic pattern of evolutionarily conserved basic and acidic residues constitutes the binding interface of actin-tropomyosin.

Authors:  Bipasha Barua; Patricia M Fagnant; Donald A Winkelmann; Kathleen M Trybus; Sarah E Hitchcock-DeGregori
Journal:  J Biol Chem       Date:  2013-02-18       Impact factor: 5.157

3.  Alteration of tropomyosin function and folding by a nemaline myopathy-causing mutation.

Authors:  J Moraczewska; N J Greenfield; Y Liu; S E Hitchcock-DeGregori
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

Review 4.  Neuroprotein Targets of γ-Diketone Metabolites of Aliphatic and Aromatic Solvents That Induce Central-Peripheral Axonopathy.

Authors:  Peter S Spencer
Journal:  Toxicol Pathol       Date:  2020-03-12       Impact factor: 1.902

5.  Distinct sites in tropomyosin specify shared and isoform-specific regulation of myosins II and V.

Authors:  Bipasha Barua; Maria Sckolnick; Howard D White; Kathleen M Trybus; Sarah E Hitchcock-DeGregori
Journal:  Cytoskeleton (Hoboken)       Date:  2018-03-26

6.  Tropomyosin ends determine the stability and functionality of overlap and troponin T complexes.

Authors:  Thomas Palm; Norma J Greenfield; Sarah E Hitchcock-DeGregori
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

7.  F-actin is intermolecularly crosslinked by N,N'-p-phenylenedimaleimide through lysine-191 and cysteine-374.

Authors:  M Elzinga; J J Phelan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Mutations in the N- and D-helices of the N-domain of troponin C affect the C-domain and regulatory function.

Authors:  L Smith; N J Greenfield; S E Hitchcock-DeGregori
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

9.  Lysine acetylation of F-actin decreases tropomyosin-based inhibition of actomyosin activity.

Authors:  William Schmidt; Aditi Madan; D Brian Foster; Anthony Cammarato
Journal:  J Biol Chem       Date:  2020-09-01       Impact factor: 5.157

10.  A peek into tropomyosin binding and unfolding on the actin filament.

Authors:  Abhishek Singh; Sarah E Hitchcock-Degregori
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.